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Abstract 
 
G-quadruplexes are higher-order nucleic acid structures formed of square-planar 
arrangements of four guanine bases held together by Hoogsteen-type hydrogen bonds. 
Stacks of guanine tetrads are stabilised by intercalating potassium ions. FXYD1 encodes for 
phospholemman, a regulatory subunit of the cardiac Na+/K+-ATPase. Computational 
sequence analysis of FXYD1 pre-mRNA predicted the formation of stable intramolecular G-
quadruplexes in human and orthologue sequences. Multiple sequence alignment indicated 
that G-rich sequences are conserved in evolution suggesting a potential role of G-
quadruplexes in FXYD1 gene expression. The existence of a non-functional alternative 
splicing product indicated that the G-quadruplex formation may control alternative splicing. 
Quadruplex formation of human and bovine oligonucleotides was confirmed in vitro by 
native polyacrylamide gel electrophoresis and intrinsic fluorescence emission spectroscopy. 
Taking together the evolutionary conservation of G-quadruplex forming sequences with the 
confirmation of G-quadruplex formation in vitro by two FXYD1 homologues the results point 
to a potential role of these structures in regulating the expression of FXYD1 and thus 
regulate indirectly the activity of the cardiac Na+/K+ -ATPase. 
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Introduction 
 
Over the last decade in-silico analysis of the human genome has revealed many potential 
sequences that can fold into G-quadruplexes, higher order secondary structures formed by 
nucleic acids rich in guanine residues. These are formed under cationic conditions[1, 2], with 
a large fraction falling into gene promoter regions, UTR regions as well as exonic and 
intronic partsof pre-mRNAs [3-5]. G-quartets,originally characterised by Gellert, Lipsett & 
Davies [6], are square planar arrangements of four guanine residues stabilised by hydrogen 
bonds. Stacks of G-tetrads form G-quadruplexes[7], which are further stabilised by cations, 
in particular potassium, located between a pair of tetrads.  
Some of the proposed biological roles of G-quadruplexes include up-regulation of genes by 
keeping promoter or upstream regions of genes in a more open conformation, providing 
easy access for transcription factors to bind [8].  Alternatively, down-regulation of genes has 
also been proposed to be associated with G-quadruplexes. This can be used for therapeutic 
intervention, for example the proto-oncogene c-myc showed reduced expression following 
the stabilisation of G-quadruplexes in its promoter [9]. Apart from DNA, G-quadruplex 
formation of RNA has been reported. G-quadruplex formation in RNA is as important as in 
DNA and the high occurrence of G-quadruplex in UTR regions lead to hypothesizing on their 
role as translational regulators [10, 11]. Kumariet al. [12] reported that a G-
quadruplexwithin the 5’-UTR of the NRAS oncogene reduced expression of the latter. G-
quadruplexes have been confirmed to regulated gene expression by influencing pre-mRNA 
splicing [16, 17]. Marcel et al. [13] reported that the formation of a G-quadruplex in the pre-
mRNA of tumour suppressor protein, P53, leads to alternative splicing. G-quadruplex 
formation in hTERT intron 6 led to alternative splicing patterns, which caused down 
regulation of the activity of telomerase in A549 carcinoma cells [14]. 
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Previous studies support the notion that conformational changes within mRNA molecules 
have the potential of regulating protein formation [15, 16] such as phospholemman (PLM) 
encoded by the FXYD1 gene. Proteins of the FXYD family are involved in regulating ion 
transport across membranes [17, 18]. PLM (FXYD1) that is mainly expressed in cardiac tissue 
acts as a modulator of the cardiac Na+/K+-ATPase (NKA) [19-21]. PLM is fundamentally 
important in the physiological regulation of cardiomyocytes and as such a potential 
therapeutic target for the treatment of cardiac hypertrophy and heart failure [22]. The 72-
residue single-span transmembrane protein forms alpha helical tetramers in vitro [23] and in 
vivo [24, 25].The tetramer has the potential to interact with NKA, which was proposed to 
lead to a subsequent dissociation of the tetramer [26]. Further in vivo studies have shown 
that there is a delicate balance between monomer and tetramer, which also depends on the 
phosphorylation of PLM [25]. X-ray crystallography studies of NKA in other tissues and 
species have shown that monomeric FXYD1 (PLM) homologs, such as FXYD2 in porcine renal 
tissue [27] and FXYD10 in the shark rectal gland [28] act as a third subunit of NKA. 
In this study we investigated the potential of a control mechanism at the level of FXYD1 
gene expression. As outlined above G-quadruplex formation of RNA has the ability to 
control gene expression by interference with splicing of the pre-mRNA. Using a combination 
of bioinformatics-based sequence analysis, energy calculations and laboratory-based 
experiments we show that FXYD1 pre-mRNA has the potential to form intramolecular G-
quadruplexes and that this potential has been conserved in evolution.  
 
Materials and Methods 
 
Computational analysis 
The online G-quadruplex prediction algorithm QGRS mapper 
(http://bioinformatics.ramapo.edu/QGRS/analyze.php) [29] was used to analyse the G-
quadruplex forming potential of FXYD1 pre-mRNA sequences. Pre-mRNA sequences were 
retrieved from the Ensembl website. Accession numbers: H. sapiens (ENST00000351325), 
M. musculus (ENSMUSG00000036570), C. familiaris( ENSCAFT00000011368), P. troglodytes 
(ENSPTRT00000020057), B. taurus (ENSBTAG00000017816), R. norvegicus 
(ENSRNOG00000021079), M. domestica (ENSMODT00000033163), F. catus 
(ENSFCAG00000008890), O. garnettii (ENSOGAG00000014401), E. caballus 
(ENSECAG00000014815), A. melanoleuca (ENSAMEG00000000212), P. abelii 
(ENSPPYG00000009851), O. cuniculus (ENSOCUG00000022123), G. gorilla 
(ENSGGOT00000026217), S. scrofa (ENSSSCT00000027321), O. aries 
(ENSOARG00000004709), T. truncates (ENSTTRG00000001446). The DNA sequence of a 
positive control DNA known to form an intramolecular G-quadruplex was obtained from the 
RCSB Protein Data Bank(PDB-ID: 2KM3). Two negative controls were generated using a 
sequence randomizer (http://www.cellbiol.com/python.html). The negative control_A has a 
similar base composition as the positive control, while the negative control_B has the same 
base composition as the highest scoring human FXYD1 G-quadruplex forming sequence 
(GQS). The Vienna RNA Package version 2.1.2 [30] was used to predict G-quadruplex and 
other secondary structure formation. Multiple sequence alignment was performed by 
multiple alignment of all 17 orthologous pre-mRNA sequences with Clustal-Omega version 
1.2.0 [31]. Comparison of the variant FXYD1-009 (retrieved from Ensembl website accession 
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number: ENST00000589121) and FXYD1-001 transcripts was carried out using the ‘1000 
Genomes’ Transcript Comparison option [32]. The effect of mutations in the pre-mRNA 
sequence were analysed for potential G-quadruplex forming sequences using QGRS mapper. 
 
Oligonucleotides 
Purified oligonucleotides were purchased from EurogentecLtd. (Southampton, UK) and used 
without further modification. Positive control DNA (AGGGCTAGGGCTAGGGCTAGGG) was 
purified by reversed phase cartridge, negative control_ADNA (CGTGGGGAGATTGGGGA 
GCGCA) and negative control_B  DNA (GGTGTGCGTGTGCGAGCGAGAGAGAGUGG) were both 
purified by reversed phase cartridge, Human FXYD1 RNA (GGGAGACUGCGGGUAUUCU 
GGGGAGAGGG) and  bovine FXYD1 RNA (GGGCGCGGGGGGUCGGGGAUCGGG) were both 
purified by reversed phase high performance liquid chromatography. Samples were 
prepared in G-quadruplex folding buffer and normal buffer to act as controls. G-quadruplex 
folding buffer was made to have final concentration of K+ of either 0.05 M or 0.1 M and 
TrisOAC at 0.02 M, pH 7.5. K+ solution was made to contain a mixture of KOAc and KCl. 
Normal buffer contained 0.02 M TrisOAC pH 7.5 only. Solutions were made using RNAase 
free water that was autoclaved prior to use. The buffer was added to the lyophilised 
oligonucleotides and shock frozen for future use. Working dilutions were prepared and 
heated to 950C for 10 mins. Following heating, the control samples and the negative DNA 
controls in the presence of K+ containing buffer were placed on ice to prevent G-quadruplex 
formation, while the positive DNA control, human and bovine FXYD1 RNA sequences 
incubated in G-quadruplex buffer were allowed to anneal for 2.5 hours to allow G-
quadruplex formation.  
 
Native polyacrylamide gel electrophoresis (PAGE) 
Separate gels were prepared for samples incubated in G-quadruplex (0.05 M and 0.1 M K+) 
and non-G-quadruplex folding buffer. The gels were prepared using 40% (w/v) acrylamide 
(acrylamide 38% (w/v), bisacrylamide 2% (w/v)), 10% ammonium persulfate (APS), sterile 
distilled water (s.d.w), 10 x TRIS-borate-EDTA (TBE), and (N,N,N′,N′-
Tetramethylethylenediamine) TEMED. Gels used for G-quadruplex samples were prepared 
with 10 X TBE + KCl + KOAc made to contain the same concentration of K+ as in the folding 
buffer. Samples used for electrophoresis were made at a final oligonucleotide concentration 
of 3 μM at a volume of 50 µl. 8 µl of tracking dye containing 1 x TBE + 20% (w/v) sucrose + 
10% (w/v) Ficoll + 10mM EDTA and 0.25% (w/v) bromophenol blue was added to each tube 
and the contents of each tube were thoroughly mixed. 12 μl of sample were loaded into 
each well. The buffers were pre-chilled at 4oC and electrophoresis was performed at 140 V 
for 3-4 hours. The gels were stained using SYBR Green I RNA stain S9430 and SYBR Green I 
nucleic S32717 and were exposed at 254 nm for 15.5s for digital snapshots. The Rf value was 
calculated as the ratio of the distance migrated by each samples to the distance migrated by 
the tracking dye. The Rf values were calculated using the software Gene Tool Syngene 
(Synoptics Ltd).  
 
Fluorescence spectroscopy 
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Samples were prepared at a final oligonucleotide concentration of 1.5 µM for RNA species 
and 5.0 µM for DNA species, which was above the minimum detectable concentrations for 
either RNA or DNA. Buffers for non G-quadruplex samples were 0.02 M TrisOAC only and 
buffers for G-quadruplex samples were 0.02 M TrisOAC + 0.1 M K+. The fluorescence 
emission spectrum was measured over the wavelength range 300-500 nm (step size 0.2 nm) 
using a Perkin Elmer LS 55 fluorimeter with a fluor cuvette Type C quartz glass having a 
10 mm light path (Whatman International Ltd Maidstone, England). Measurements were 
repeated three times to ensure reproducibility. Samples were excited at 260 nm and both 
excitation and emission slit widths were set at 5 nm. The scan rate was 150 nm/min. 
Emission spectra of buffers were also measured. The original spectra were smoothed with a 
moving average of 30 data points. UV/VIS spectra of each sample in a wavelength range of 
200-400 nm were recorded using a dual beam UV/VIS CARY 100 (Varian Inc.) 
spectrophotometer.  
 
Results and Discussion 
 
In-sillico analysis of FXYD1 pre-mRNA and orthologuesrevealed potential G-quadruplex 
forming sequences.  
The sequences of FXYD1 pre-mRNA and orthologues were obtained from  the Ensembl 
database and analysed with QGRS mapper[29]. QGRS-mapper scans the sequence for 
characteristic G-rich motifs and provides a score that indicates the potential for G-
quadruplex formation.  
 
The results in table 1 show that all seventeen orthologues have sequences that can 
potentially fold into a G-quadruplex, in the following referred to as predicted G-Quadruplex 
forming Sequences (GQS). The G-scores are in the same region as the positive control, which 
has a G-score of 42. The positive control is a DNA oligonucleotide definitively known to form 
G-quadruplexes with the 3-dimensional structure obtained by NMR spectroscopy [33]. The 
negative controls are randomised DNA oligonucleotides of the same base composition as 
the positive control (A) and human FXYD1 GQS (B) respectively. The negative controls did 
not show G-quadruplex forming potential with a G-score of zero, as would be expected due 
to the absence of four stretches of consecutive guanine bases. With the exception of S. 
Scrofa, R. Norvegicus and G. gorilla, all orthologue sequences have comparable G-scores to 
the positive control. Most of the QGS listed in table 1 occur in intronic parts of the pre-
mRNA. For instance the H. sapiensGQS is intronic between exons 6 and 7, a position shared 
with four other orthologues. 
Prediction of potential GQS relies on Kikin and colleagues’ folding rule: GxNy1GxNy2GxNy3Gx 
[29]. G represents guanine residues taking part in G-tetrad formation and x is the number of 
successive guanines. According to the folding rule, x is always constant and should be at 
least two, as a minimum of two quartets is required to stack on top of each other to form a 
G-quadruplex. The lower scoring GQS will have two G-tetrads in its G-quadruplex entity, 
similar to R. Norvegicus and G. gorilla’s GQS. Stability is enhanced by more G-quartets or the 
number of guanine residues participating in the stacks. N is representative of the other 
bases involved in the loops of the G-quadruplex, N can be any base including guanine. y1, y2 
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& y3 are the frequency of the different residues that participate in the three different loops, 
and can vary. Loop size can affect stability of G-quadruplex ensembles but not as much as 
the frequency of guanine bases. GQSs having at least three guanine tetrads and loops of 
equal length connecting them will be highly stable and have high G-scores such as the 
positive control. The GQS predicted for S. scrofa has a G-score of 83, which makes its G-
quadruplex twice as stable as that of the +VE control. S. scrofa has five G-quartets that form 
a G-quadruplex of equal loop length of one base each, which make the G-quadruplex highly 
stable, hence yielding a high G-score. Regardless of the equally sized loops connecting the  
two G-tetrads inall six of  R. norvegicus’ and G. gorilla’sGQS, theirscoresarehalf than that of 
the positive control,due to two G-tetrads only present in the GQS. 
 
RNA secondary structure and minimum free energy calculations  
Using a combination of RNA secondary structure calculations and G-quadruplex minimum 
free energy (MFE) calculations as implemented in the Vienna RNA Package 2.1 it was 
suggested that the majority of G-quadruplex forming sequences (GQS) may form canonical 
secondary structures instead [34]. Therefore, we calculated the MFE of the predicted most 
stable structure as well as the MFE of suboptimal structures for the human and bovine GQS 
shown in table 1 using the Vienna RNA package.  
 
The results in table 2 show that the positive control and Bos taurus QGS are clearly most 
stable in the G-quadruplex form. For the Homo Sapiens QGS the situation is more complex, 
the most stable form with MFE = -4.3 kcal/mol is a secondary structure based on canonical 
base pairing, closely followed by another secondary structure, while the G-quadruplex 
structure has an MFE of -3.51 kcal/mol. These MFE values can be used to estimate the 
relative amountof secondary structure in equilibrium with G-quadruplex structure assuming 
that the MFE values correspond approximately to the free enthalpy of folding ΔG. Defining 
K1 = [G4]/[U] as the equilibrium constant for the formation of the G-quadruplex structure 
from the unfolded state, and K2 = [2°]/[U] as the equilibrium constant for the formation of 
secondary structure, then K2/K1 = [2°]/[G4] can be calculated from the MFE values as K2/K1 = 
exp(-(MFE2° - MFEG4)/RT) = 3.8  (with R = 1.987∙10-3 kcal K-1 mol-1, T = 298 K) meaning that 
the concentration of the secondary structure is approximately four-fold higher than the G-
quadruplexstructure.Note that inaccuracies in MFE values are partially compensated for by 
considering the difference in the calculation above. This result shows that in case of Homo 
Sapiens QGS there is a significant proportion of G-quadruplex structure present, which may 
increase upon increasing potassium concentration. Note that the energy model of the 
Vienna RNA package for G-quadruplex structures did not take the potassium ion 
concentration into account [34]. 
 
 
G-quadruplex forming sequences (QGS) are evolutionary conserved among orthologous 
FXYD1 pre-mRNA. 
The human pre-mRNA was aligned withthe pre-mRNA sequences of  seventeen orthologues. 
The results shown in figure 1 reveal G-rich sequences that align with the human GQS (shown 
in the first line of table 1), except in Monodelphisdomestica. In particular the human GQS 
aligns with GQS from Canis lupus and Pan troglodytes, while the other organisms have GQS 
in other parts of the sequence as shown in table 1. Furthermore, the consensus sequence of 
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the multiple alignment has G-quadruplex forming potential, as it shows four stretches of at 
least three consecutive Gs. The existence of evolutionary conserved GQS based on a 
pairwise alignment of two sequences has been proposed as a method of validation and 
emphasis of their functional significance [35]. The presence of G-rich sequences in 
orthologues points to an evolutionary conservation of that feature, which supports the 
hypothesis that G-quadruplex formation, is a control mechanism of FXYD1 pre-mRNA 
processing.  
 
Analysis of FXYD1 transcripts suggest alternative splicing 
FXYD1 has 10 splice variants as listed in the Ensembl database. Among those only FXYD1-
009, based on manual annotation by the HAVANA project [36], expresses a different longer 
peptide (115 aa), which lacks the membrane targeting signal.  The comparison between H. 
sapiens’ FXYD1 genomic sequence and its splice variants FXYD1-009 and FXYD1-001 suggests 
an alternative 3’ splice site, which leads to a partially spliced intron four of the FXYD1-pre 
mRNA that produces FXYD1-009. The protein product of the splice variant 0009 lacks the 
signal peptide in its polypeptide chain, which means translocation of FXYD1 to the cell 
membrane is impaired, thus limiting the association between FXYD1 and the sodium pump. 
 A comparison of the of the FXYD1-01 and FXYD1-009 was performed using the ‘1000 
Genomes Transcript comparison’ option.  H. sapiens’ highest scoring GQS, 
GGGAGACUGCGGGUAUUCUGGGGAGAGGG, was compared in the two pre-mRNA transcripts 
for mutations. In the second loop of the GQS an A ->G substition was found and a G -> A 
substitution in the fourth quartet, the latter of which affects G-quadruplex stablity. 
Computational analysis of the GQS with the A->G substition predicts a low stability G-
quadruplex based on the QGRS mapper (G-score 14) and no G-quadruplex formation was 
predicted based on minimum free energy calculations. 
Whilst the exact mechanism of G-quadruplex involvement in pre-mRNA splicing is not 
understood, it was reported that G-quadruplexes can regulate splicing of RNA [16, 17]. The 
analysis suggests a potential influence of the G-quadruplex from intron six of FXYD1 in the 
full splicing of intron four.  
 
Native gel-electrophoresis indicates that human and bovine FXYD1-derived synthetic 
oligonucleotides form G-quadruplexes in vitro.  
Native polyacrylamide gel electrophoresis (PAGE) has been used to detect the presence of 
intramolecular G-quadruplexes due to the faster migration of the more compact G-
quadruplex structure compared to the extended oligonucleotide [37, 38]. 
 
Figure 2 shows examples of native PAGE of human and bovine GQS together with controls. 
The oligonucleotide sequences used are given in table 1. Comparing the gel without K+ ions 
(Figure 2A) and the gel with 0.1 M K+ it is apparent that human and bovine QGS (lanes 4 and 
5) migrate faster and at the same time show a smear of intensity along the lane. The faster 
migration indicates G-quadruplex formation in the presence of K+ of human and bovine 
FXYD1-derived GQS. Intramolecular G-quadruplexes are compact in shape and confer high 
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mobility rates in gels in comparison to linear species and intermolecular G-quadruplexes 
[37, 38]. The smear of intensity can be interpreted as the formation of secondary structures 
as indicated by the minimum free energy calculations above. The negative control_A sample 
(lanes 2 in Figure 2) showed in addition to the expected band a band at high molecular mass 
in the presence of potassium. This can be attributed to the formation of intermolecular G-
quadruplexes, which is possible in negative control_A since the oligonucleotide has two 
stretches of four consecutive guanine bases. This could lead to intermolecular G-
quadruplexes in either a dimeric or tetrameric arrangement.These observations are also 
supported by fluorescence emission spectroscopy comparing negative control_A with 
negative control_B as shown in the next section. The absolute Rf values depend on the 
molecular massas well as the conformation of the oligonucleotides. Negative control_A 
(DNA) has the same molecular mass as the positive control and shows the same Rf value as 
the positive control (DNA) in the absence of potassium. The absolute Rf values of negative 
control_B with Homo sapiens GQS cannot be directly compared as they are chemically 
different, i.e. DNA vs RNA. In order to obtain samples of the highest purity and stability, DNA 
was chosen for all control samples. 
Native PAGE of short oligonucleotides is experimentally challenging and may lead to 
variable results. Therefore five different experiments were performed for each K+ 
concentration of 0 M, 0.05 M and 0.1 M, and the relative migration distance Rf was 
calculated (Figure 3). The average of five experiments revealed a clear trend for an increase 
of the relative migration distance Rf with increasing potassium concentration for human and 
bovine GQS. The same trend was observed with the positive control, a sequence known to 
form G-quadruplexes, but not with the negative controls. The difference between Rf values 
for the positive control and human/bovine QGS sequences is statistically significant at p < 
0.05 for both 0.05 M and 0.1 M K+ buffer as shown in table 3. 
 
Fluorescence spectroscopy confirms the formation of G-quadruplex in FXYD1 pre-mRNA. 
Fluorescence emission profiles of samples were determined in the presence and absence of 
K+ and are shown in Figure 4. Comparison of positive control with human and bovine GQS 
shows an increase in fluorescence emission intensity in 0.1 M K+ buffer compared to a buffer 
without potassium ions, while the negative control_B does not show any increase. G-
quadruplex entities have been reported to have increased fluorescence emission intensity in 
contrast to non-G-quadruplex complexes due to the stacking of G-tetrads [46, 47]. 
Therefore, the data shown in Figure 4 are a strong indication of G-quadruplex formation of 
RNA oligonucleotides derived from FXYD1 pre-mRNA. Comparing the human and bovine 
GQS, it is notable that the human RNA shows higher fluorescence emission even in the 
absence of potassium ions. A possible explanation is formation of secondary structures, 
which would alter the fluorescence emission spectrum. This possibility was also indicated by 
energy calculations and gel electrophoresis results that have been discussed above. 
However, there is a further increase of the fluorescence intensity in K+-containing buffer, 
which cannot be explained by further secondary structure formation. 
 
Interestingly, the negative control_A sample showed an increase in fluorescence intensity 
similar to the positive control.The increase of fluorescence intensity in the negative 
control_A sample is due to intermolecular G-quadruplexes that was already indicated by gel 
electrophoresis experiments. At a final oligonucleotide concentration of 5 μM, as reported 
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by Moon and Jarsfer [48], intermolecular G-quadruplexes are highly favoured and migrate 
on gels even slower than linear non-G-quadruplex samples. Therefore, the fluorescence 
experiments are capable of detecting intra- and inter-molecular G-quadruplexes. 
 
 
Conclusions 
 
In conclusion, using a computational scan of the FXYD1 pre-mRNA potential G-quadruplex 
forming sequences (GQS) were identified in Homo sapiens, Bos taurus and other 
orthologues. Through energy calculations it was established that the G-quadruplex was 
either the most stable structure or existent in a significant proportion next to secondary 
structures. The stability of these G-quadruplex structures is likely higher in vivo considering 
the intracellular K+ concentration of 120-150 mM. Using native PAGE and fluorescence 
emission spectroscopy the theoretical calculations were confirmed and the existence of G-
quadruplex structures established. Multiple sequence alignment of orthologue GQS 
confirmed that the G-quadruplex forming potential is conserved in evolution, indicating a 
possibility that it may occur in vivo as a mechanism to control phospholemman expression 
levels and ultimately the activity of the cardiac sodium-potassium ATPase. Since 
FXYD1/phospholemman has been proposed as a potential therapeutic target for the 
treatment of cardiac hypertrophy and heart failure[22] modulating the G-quadruplex 
formation of FXYD1 pre-mRNA with small molecules or siRNA could have a future in the 
therapy of heart disease. 
 
Further work should address the consequences of G-quadruplex structure on the splicing of 
pre-mRNA, which may be a reduced splicing activity or alternative splicing that will cause 
expression of the variant FXYD1-009. Additionally, the existence of G-quadruplex formation 
and the consequences of it should be confirmed in vivo. 
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Tables 
Table 1:  The highest scoring predicted G-Quadruplex forming Sequences (GQS) from FXYD1 
orthologues and their location within the gene. The analysis was performed with QGRS 
mapper [29].  
 
 
Organism Sequence of highest scoring GQS G-
score 
Genomic 
location1 
Homo sapiens GGGAGACUGCGGGUAUUCUGGGGAGA
GGG 
39 Intronic (6:7) 
Musmusculus GGGAGGAAGGAGGGAGAGGGGUUUGG
AGGG 
38 Intronic (7:8) 
Canis lupus GGGGGCGAAGGGUGGGCUGGGAUGGC
CGGG 
42 3’-UTR 
Pan troglodytes GGGAGACUGCGGGUAUUUUGGGGAGA
GGG 
GGGUUGAAGGGCGGCGAGGGGUGGGG 
39 
39 
Intronic (6:7) 
Intronic (7:8) 
Bostaurus GGGCGCGGGGGGUCGGGGAUCGGG 42 Intronic (6:7) 
 
 
Rattus norvegicus 
GGGCAGGUGAGGCUGGG 
GGAUGGAAGGUAGG 
GGCGGUGGGGG 
GGCACGGGGAGGUAAGG 
GGGAGGAAGGAGGG 
GGCGGGUUGGAGGG 
21 
21 
21 
21 
21 
21 
Intronic (1:2) 
Intronic (2:3) 
Intronic (5:6) 
Intronic (5:6) 
Intronic (7:8) 
Intronic (7:8) 
Feliscatus GGGAGACUUUGGGGGUUUGGGGGUGA
GGG 
40 Intronic (5:6) 
Otolemurgarnettii GGGCGCAGGGUGGGGUGGGUGAGGCG
GG 
40 Intronic (4:5) 
Tursiopstruncatus GGGAGUUAGGGGGUGCUGGGCUGGG 38 Intronic (2:3) 
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Equuscaballus GGGAGUUGGGGAGUGGGGUUUGGG 42 Intronic (3:4) 
Ailuropodamelanoleuca GGGAGACUUCGGGUGUUUGGGGGUGA
GGG 
40 Intronic (5:6) 
 
Pongoabelii 
GGGAGACUGCGGGUAUUUUGGGGAGA
GGG 
GGGUUGAAGGGCGGCGAGGGGUGGGG 
39 
39 
Intronic (5:6) 
Intronic (6:7) 
Oryctolaguscuniculus GGGAGAGUGGGUGGGGGUCCUGGG 40 Intronic (5:6) 
Gorilla gorillagorilla GGUGGCGGUGG 21 Intronic (1:2) 
Sus scrofa GGGGGUGGGGGUGGGGGUGGGGG 83 Intronic (2:3) 
Ovisaries GGGCUGGGGCAAAGGGGGAGGG 41 Intronic (1:2) 
Monodelphisdomestica GGGGGUGGGGAGGAGGGAUGGG 
GGGAGAUGGGGGGGGGUAGGUGGG 
40 
40 
5’-UTR 
Intronic (2:3) 
positive control2 AGGGCTAGGGCTAGGGCTAGGG 42 N/A 
negative control_A3 CGTGGGGAGATTGGGGAGCGCA 0 N/A 
negative control_B GGTGTGCGTGTGCGAGCGAGAGAGAG
TGG 
0  N/A 
 
1 The genomic location specifies the intron between the numbered exons 
2 The G-quadruplex structure of this DNA sequence was determined by nuclear magnetic 
resonance (Protein databank-ID: 2KM3) 
3 All controls were DNA. The negative control_A is a randomised sequence with the same 
base composition as the positive control. The negative control_B has the same base 
composition as the Homo Sapiens GQS. 
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Table 2: Most stable RNA structures predicted by RNAfold from the Vienna RNA package 
and minimum free energy (MFE). In case the G-quadruplex was not the most stable 
structure the MFE of suboptimal structures was calculated with RNAeval. 
 
Sample Name Dot bracket notation1 MFE  
in kcal/mol 
positive control AGGGCTAGGGCTAGGGCTAGGG 
.+++...+++...+++...+++  
 
-12.65 
negative control_A CGTGGGGAGATTGGGGAGCGCA 
.(((..............))).  
 
-0.30  
negative control_B GGUGUGCGUGUGCGAGCGAGAGAGAGUGG 
.((.(((....))).))............  
-2.70  
Homo sapiens QGS GGGAGACUGCGGGUAUUCUGGGGAGAGGG 
......((.(((.....))).))......  
.......((.((((...)))).)).....  
+++.......+++......+++....+++  
 
-4.30  
-4.10  
-3.51  
Bostaurus QGS GGGCGCGGGGGGUCGGGGAUCGGG 
+++...+++.....+++....+++  
 
-8.37  
1  The symbols ‘(‘ and ‘)’ represent canonical base pairs, ‘+’ represents guanine bases taking 
part in G-tetrad formation, ‘.’ represents unpaired bases 
 
 
Table 3: P-values obtained from a Student two-tailed-t-test of Rf values comparing samples 
with K+-buffer with samples in K+ free buffer. 
 
[K+] 
in M  
Positive 
control 
Negative 
control_A 
Negative 
control_B 
Human GQS Bovine GQS 
 0.05 4.2∙10-5 0.74 0.46 3.3∙10-6 2.0∙10-7 
 0.10 4.2∙10-7 0.72 0.34 3.1∙10-7 5.3∙10-11 
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Figures 
 
 
Figure 1: Multiple sequence alignmentof pre-mRNAs from H. sapiens and orthologues. The 
H. sapiensGQS sequence from Table 1 was highlighted.Note that the sequences shown are 
based on the best alignment to the human GQS and the highest scoring GQS of that 
particular organism. The dashes stand for gaps inserted by the multiple alignment algorithm 
to achieve the best match between the sequences. 
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Figure 2: Native 30% PAGE of GQS oligos (table 1) in absence and presence of K+ions. 
Lanes1: positive control; 2:negativecontrol_A; 3:negative control_B; 4:human GQS; 5:bovine 
GQS. A. Samples incubated in 0.02 M TrisOAc buffer solution without K+ ions. The positive 
and negative control_A controls migrated at the same rate on the gel. Negative control_B 
migrated less than other controls but faster than human and bovine GQS. Human GQS was 
the slowest migrating sample. B.Samples incubated in buffer with 0.05 M 
K+concentration.The positive control was the fastest migrating sample. The bovine QGS now 
migrated faster than negative control_B. In the order of fastest to slowest migrating sample: 
positive control  > negative control_A> bovine GQS > negative control_B> human GQS. 
C.Samples incubated in buffer with 0.10 M K+concentration.Samples migrated with a similar 
trend as seen in B. 
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Figure 3: Average relative migration distances Rf from n=5 experiments obtained from 
native PAGE experiments for samples treated in K+ free and K+ containing buffer.  
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Figure 4: Fluorescence emission spectra of samples excited at 260 nm in the presence of K+ 
and absence of K+ (blue and red curves). In addition the spectra of buffers were recorded 
(green and black curves). The oligonucleotide concentration was 5 μM for the DNA controls 
and 1.5μM for RNA samples.  
 
